| Issue Date | Title | Author(s) |
| 2014 | ALK-positive anaplastic large cell lymphoma with an unusual alveolar growth pattern | Yu, Guohua; Gao, Zifen; Huang, Xin |
| Jun-2023 | Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer | Lei, Huizi; Ling, Yun; Yuan, Pei; Yan, Xieqiao; Wang, Lin; Shi, Yanxia; Yao, Xin; Luo, Hong; Shi, Benkang; Liu, Jiyan; He, Zhisong; Yu, Guohua; Han, Weiqing; Hu, Changlu; Chi, Zhihong; Cui, Chuanliang; Si, Lu; Fang, Jianmin; Guo, Jun; Sheng, Xinan; Zhou, Aiping; Ying, Jianming |
| 2018 | Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey | Chen, Liang; Zhou, Fei; Li, Hui; Xing, Xiqian; Han, Xiudi; Wang, Yiming; Zhang, Chunxiao; Suo, Lijun; Wang, Jingxiang; Yu, Guohua; Wang, Guangqiang; Yao, Xuexin; Yu, Hongxia; Wang, Lei; Liu, Meng; Xue, Chunxue; Liu, Bo; Zhu, Xiaoli; Li, Yanli; Xiao, Ying; Cui, Xiaojing; Li, Lijuan; Uyeki, Timothy M.; Wang, Chen; Cao, Bin |
| Oct-2021 | Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study | Peng, Zhi; Liu, Tianshu; Wei, Jia; Wang, Airong; He, Yifu; Yang, Liuzhong; Zhang, Xizhi; Fan, Nanfeng; Luo, Suxia; Li, Zhen; Gu, Kangsheng; Lu, Jianwei; Xu, Jianming; Fan, Qingxia; Xu, Ruihua; Zhang, Liangming; Li, Enxiao; Sun, Yuping; Yu, Guohua; Bai, Chunmei; Liu, Yong; Zeng, Jiangzheng; Ying, Jieer; Liang, Xinjun; Xu, Nong; Gao, Chao; Shu, Yongqian; Ma, Dong; Dai, Guanghai; Li, Shengmian; Deng, Ting; Cui, Yuehong; Fang, Jianmin; Ba, Yi; Shen, Lin |
| 26-Jan-2021 | Exploring the Active Components of Simotang Oral Liquid and Their Potential Mechanism of Action on Gastrointestinal Disorders by Integrating Ultrahigh-Pressure Liquid Chromatography Coupled with Linear Ion Trap-Orbitrap Analysis and Network Pharmacology | Luo, Zhiqiang; Yu, Guohua; Han, Xing; Liu, Yang; Wang, Guopeng; Li, Xueyan; Yang, Haiyang; Sun, Wenyan |
| 2015 | Histopathological Image in Hematology | Yu, Guohua; Huang, Xin; Huo, Yuqing; Zhang, Tingguo; Gao, Zifen |
| 2021 | Integrated Systems Pharmacology and Surface Plasmon Resonance Approaches to Reveal the Synergistic Effect of Multiple Components of Gu-Ben-Ke-Chuan Decoction on Chronic Bronchitis | Luo, Zhiqiang; Yu, Guohua; Wang, Wubin; Sun, Rui; Zhang, Binbin; Wang, Jing; Liu, Jing; Gao, Shan; Wang, Peng; Shi, Yuanyuan |
| 1-Jan-2021 | Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma | Sheng, Xinan; Yan, Xieqiao; Wang, Lin; Shi, Yanxia; Yao, Xin; Luo, Hong; Shi, Benkang; Liu, Jiyan; He, Zhisong; Yu, Guohua; Ying, Jianming; Han, Weiqing; Hu, Changlu; Ling, Yun; Chi, Zhihong; Cui, Chuanliang; Si, Lu; Fang, Jianmin; Zhou, Aiping; Guo, Jun |
| 20-May-2021 | An open-label, single-arm, multicenter, phase II study of RC48-ADC to evaluate the efficacy and safety of subjects with HER2 overexpressing locally advanced or metastatic urothelial cancer (RC48-C009). | Sheng, Xinan; He, Zhisong; Han, Weiqing; Zhou, Ai-Ping; Luo, Hong; Shi, Yanxia; Hu, Changlu; Liu, Ziling; Guo, Hongqian; Yao, Xin; Shi, Benkang; Liu, Jiyan; Ji, Zhigang; Guo, Jianming; Hu, Yi; Yu, Shi Ying; Yu, Guohua; Ying, Jianming; Fang, Jianmin; Guo, Jun |
| Jul-2021 | Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer | Wang, Jiani; Zhang, Qingyuan; Li, Qiao; Mu, Yuxin; Jing, Jing; Li, Huiping; Li, Wei; Wang, Jingfen; Yu, Guohua; Wang, Xian; Ouyang, Quchang; Hao, Jing; Lu, Liang; Zhou, Li; Guan, Jin; Li, Qing; Xu, Binghe |
| 2019 | A phase II study of RC48-ADC in HER2-positive patients with locally advanced or metastatic urothelial carcinoma. | Sheng, Xinan; Zhou, Ai-Ping; Yao, Xin; Shi, Yanxia; Luo, Hong; Shi, Benkang; Liu, Jiyan; Yu, Guohua; He, Zhisong; Hu, Changlu; Han, Weiqing; Fang, Jianmin; Guo, Jun |
| 1-Jun-2022 | RC48-ADC for metastatic urothelial carcinoma with HER2-positive: Combined analysis of RC48-C005 and RC48-C009 trials. | Sheng, Xinan; He, Zhisong; Shi, Yanxia; Luo, Hong; Han, Weiqing; Yao, Xin; Shi, Benkang; Liu, Jiyan; Hu, Changlu; Liu, Ziling; Guo, Hongqian; Yu, Guohua; Ji, Zhigang; Yu, Shiying; Hu, Yi; Guo, Jianming; Ying, Jianming; Fang, Jianmin; Zhou, Aiping; Guo, Jun |
| 2019 | Rubus chingii Hu: A Review of the Phytochemistry and Pharmacology | Yu, Guohua; Lu, Zhiciiang; Wang, Wubin; Li, Yihao; Zhou, Mating; Shi, Yuanyuan |
| 10-Sep-2022 | Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study | Shen, Lin; Kato, Ken; Kim, Sung-Bae; Ajani, Jaffer A.; Zhao, Kuaile; He, Zhiyong; Yu, Xinmin; Shu, Yongqian; Luo, Qi; Wang, Jufeng; Chen, Zhendong; Niu, Zuoxing; Zhang, Longzhen; Yi, Tienan; Sun, Jong-Mu; Chen, Jianhua; Yu, Guohua; Lin, Chen-Yuan; Hara, Hiroki; Bi, Qing; Satoh, Taroh; Pazo-Cid, Roberto; Arkenau, Hendrick-Tobias; Borg, Christophe; Lordick, Florian; Li, Liyun; Ding, Ningning; Tao, Aiyang; Shi, Jingwen; Van Cutsem, Eric |
| 2019 | Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in Chin | Zhang, Zhu; Lei, Jieping; Shao, Xiang; Dong, Fen; Wang, Jing; Wang, Dingyi; Wu, Sinan; Xie, Wanmu; Wan, Jun; Chen, Hong; Ji, Yingqun; Yi, Qun; Xu, Xiaomao; Yang, Yuanhua; Zhai, Zhenguo; Wang, Chen; Zhang, Jin; Zhang, Peng; Mao, Yimin; Yang, Xiaohong; Xu, Xiaomao; Xia, Guoguang; Zheng, Rui; Gao, Yuan; Zhu, Guangfa; Zhu, Chenxi; Fu, Yingyun; Chen, Hong; Yu, Fangfei; Kuang, Jiulong; Li, Ziqiang; Cheng, Zhe; Wu, Rui; Cheng, Zhaozhong; Tong, Li; Jiang, Yanwen; Sun, Jie; Xu, Qixia; Pan, Huiyun; Wang, Lihong; Zeng, Mian; Chen, Yanzhu; Yu, Chunxiao; Hua, Jing; Tang, Yongjun; Ji, Yingqun; An, Jun; Zhang, Yongxiang; Ding, Yanyan; Zhang, Wei; Wu, Xiaomai; Chai, Wenshu; Li, Jing; Yi, Qun; Wang, Haixia; Chen, Xiaoju; Zhang, Aizhen; Han, Jun; Ying, Kejing; Xu, Xiaoling; Shi, Zhihong; Sun, Jiaolin; Zhao, Qiuliang; Liu, Guangjie; Zhuo, Jie; Shi, Guochao; Ding, Yongjie; He, Zhihong; Lang, Zhe; Hu, Xiaoyun; Fan, Fangfang; Liu, Hong; Sun, Guohua; Xing, Guoqiang; Zhang, Yingqi; Su, Guanli; Ni, Jixiang; Zhao, Tianming; Wang, Jun; Zhang, Nuofu; Qin, Simin; Huang, Songping; Xu, Qinghua; Li, Yunqiu; Liu, Qian; Wu, Qi; Li, Li; Chen, Xisheng; Niu, Zhiwei; Huang, Jianan; Zeng, Daxiong; Yuan, Yadong; Tian, Qian; Zhang, Jian; Han, Xinpeng; Yang, Jingping; Bo, Baoying; Huang, Yurong; Luo, Qian; Pang, Guifen; Zheng, Hongfei; Zhang, Ping; Xu, Ruhong; Zhang, Yunfeng; Ni, Songshi; Li, Shengqing; Gong, Yi; Zhang, Jie; Zhu, Ling; Xia, Shuyue; Chang, Yule; Zhang, Jian; Han, Xinpeng; Yuan, Yadong; Tian, Qian; Zhang, Hongyu; Xu, Xia; Zhang, Yiwen; Pan, Jingjing; Qin, Zhiqiang; Lao, Miaochan; Li, Jing; Liu, Zhihong; Luo, Qin; Wang, Jun; Wang, Ning; Yang, Huiqin; Tang, Xiaoli; Bai, Xiaomin; Chen, Yanwei; Han, Dan; Shen, Shasha; Jin, Chen; Ye, Yanping; Suo, Lijun; Huang, Xiaoying; Wang, Jialie; Zhang, Xiangyan; Yang, Guoru; Yu, Guohua; Zhang, Shudong; Yang, Yinlou; Cheng, Jiangtao; Duo, Jie; Zhang, Hong; Wang, Ping; Li, Yueyue; Wang, Ping; Guo, Changcheng; Bian, Tao; Cai, Shaoxi; Cheng, Zhenshun; Wang, Ting; He, Yong; Huang, Wentong; Liu, Chengying; Zhao, Hongda; Tu, Fenglin; Zhu, Youming; Tian, Guizhen |
| 2019 | Uncovering the pharmacological mechanism of Carthamus tinctorius L. on cardiovascular disease by a systems pharmacology approach | Yu, Guohua; Luo, Zhiqiang; Zhou, Yating; Zhang, Lei; Wu, Yang; Ding, Lei; Shi, Yuanyuan |
